RI 36 (Oxymorphone Hydrochloride Extended-Release 7.5 mg)
Pill with imprint RI 36 is Gray, Round and has been identified as Oxymorphone Hydrochloride Extended-Release 7.5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..
Oxymorphone is used in the treatment of pain; labor pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Oxymorphone 7.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RI 36
Oxymorphone Hydrochloride Extended-Release
- Imprint:
- RI 36
- Strength:
- 7.5 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63304-0219
More about oxymorphone
- Oxymorphone Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 207 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (1)
Consumer resources
- Oxymorphone
- Oxymorphone Extended-Release Tablets
- Oxymorphone Injection
- Oxymorphone Tablets
- Oxymorphone (Advanced Reading)
- Oxymorphone Injection (Advanced Reading)
Other brands: Opana, Opana ER, Numorphan
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
